OptimizeRx Corporation

(NASDAQ:OPRX)

Latest On OptimizeRx Corporation (OPRX):

Date/Time Type Description Signal Details
2023-05-11 09:05 ESTNewsOptimizeRx Corporation (OPRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:14 ESTNewsOptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64MN/A
2023-05-10 05:58 ESTNewsOptimizeRx Q1 2023 Earnings PreviewN/A
2023-04-04 01:29 ESTNewsOptimizeRx Has A Good Growth Path AheadN/A
2023-03-14 08:26 ESTNewsOptimizeRx launches $15M stock buyback planN/A
2023-03-09 20:46 ESTNewsOptimizeRx bags contract with Hub services company for better patient accessN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensusN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19%N/A
2023-03-09 05:10 ESTNewsOptimizeRx Corporation (OPRX) Q4 2022 Earnings Call TranscriptN/A
2022-11-09 10:21 ESTNewsOptimizeRx Corporation (OPRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 17:11 ESTNewsOptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08MN/A
2022-11-07 23:01 ESTNewsOptimizeRx Q3 2022 Earnings PreviewN/A
2022-10-25 15:02 ESTNewsOptimizeRx: A Digital Health Marketing Firm That Has Fallen On Hard TimesN/A
2022-10-12 08:35 ESTNewsOptimizeRx: A Top Candidate For My Speculative 'Bio Boom' PortfolioN/A
2022-08-10 21:45 ESTNewsOptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woesN/A
2022-08-10 04:11 ESTNewsOptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensusN/A
2022-08-10 04:11 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:21 ESTNewsOptimizeRx Q2 2022 Earnings PreviewN/A
2022-07-26 19:41 ESTNewsOptimizeRx extends reach with Cooler Screens PartnershipN/A
2022-06-27 13:25 ESTNewsOptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In ProfitabilityN/A
2022-06-26 19:34 ESTNewsOptimizeRx (OPRX) Investor Presentation - SlideshowN/A
2022-05-17 14:46 ESTNewsOptimizeRx authorizes $20M share repurchase programN/A
2022-05-05 07:30 ESTNewsOptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18MN/A
2022-05-05 07:29 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 18:55 ESTNewsOptimizeRx Q1 2022 Earnings PreviewN/A
2022-03-16 08:15 ESTNewsOptimizeRx to acquire specialty drug prescription platform EvincemedN/A
2022-02-25 12:37 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 17:00 ESTNewsOptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5MN/A
2022-02-24 00:04 ESTNewsOptimizeRx Q4 2022 Earnings PreviewN/A
2022-02-16 04:57 ESTNewsOptimizeRx announces preliminary Q4 resultsN/A
2021-11-10 13:38 ESTNewsOptimizeRx EPS misses by $0.04, beats on revenueN/A
2021-11-10 13:38 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:32 ESTNewsOptimizeRx Q3 2021 Earnings PreviewN/A
2021-09-30 20:19 ESTNewsOptimizeRx names Edward Stelmakh as CFO and COON/A
2021-09-29 20:59 ESTNewsOptimizeRx jumps 11% on addition to SmallCap 600 indexN/A
2021-08-05 10:49 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:39 ESTNewsOptimizeRx inks collaboration agreement to drive new patient affordability initiativeN/A
2021-04-20 09:36 ESTNewsOptimizeRx Stock Is Just Getting StartedN/A
2021-03-17 05:40 ESTNewsOptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenueN/A
2021-03-02 12:13 ESTAnalyst RatingThe Analyst Target Price has increased from $65.33 to $75.33.Buy
2021-02-26 12:08 ESTAnalyst RatingThe Analyst Target Price has increased from $61.33 to $65.33.Buy
2021-02-26 04:22 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.07 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.78 is estimated for the 2022 year.Buy
2021-02-25 07:12 ESTNewsOptimizeRx EPS beats by $0.01, beats on revenueN/A
2021-02-25 07:10 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 16:32 ESTNewsOptimizeRx announces proposed public offeringN/A
2021-02-10 16:31 ESTNewsOptimizeRx priced its stock offeringN/A
2021-01-26 12:20 ESTAnalyst RatingThe Analyst Target Price has increased from $53.33 to $61.33.Buy
2021-01-25 20:45 ESTNewsOptimizeRx trades high on positive Q4 guidanceN/A

About OptimizeRx Corporation (OPRX):

OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

OPRX Quotes by TradingView

See Advanced Chart

General

  • Name OptimizeRx Corporation
  • Symbol OPRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryHealth Information Services
  • Full Time Employees 71
  • Last Split Factor1:3
  • Last Split Date2018-05-14
  • Fiscal Year EndDecember
  • IPO Date1996-10-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Technology
  • Gic SubIndustryHealth Care Technology
  • Web URLhttp://www.optimizerx.com
View More

Valuation

  • Forward PE 96.15
  • Price/Sales (Trailing 12 Mt.) 15.5
  • Price/Book (Most Recent Quarter) 15.23
  • Enterprise Value Revenue 17.34
  • Enterprise Value EBITDA 467.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.44
  • Next Year EPS Estimate $0.81
  • Next Quarter EPS Estimate $0.03
  • Profit Margin -5%
  • Operating Margin -3%
  • Return on Assets -1%
  • Return on Equity -5%
  • Revenue 43.31 million
  • Earnings Per Share $0.04
  • Revenue Per Share $2.92
  • Gross Profit 24.11 million
  • Quarterly Earnings Growth 122.6%
View More

Highlights

  • Market Capitalization 839.66 million
  • EBITDA 646895
  • PE Ratio -9.25
  • PEG Ratio 1.93
  • Analyst Target Price $75.33
  • Book Value Per Share $3.28
View More

Share Statistics

  • Shares Outstanding 16.81 million
  • Shares Float 14.36 million
  • % Held by Insiders 1791%
  • % Held by Institutions 65.76%
  • Shares Short 871014
  • Shares Short Prior Month 930303
  • Short Ratio 2.63
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.66
  • 52 Week High $63.98
  • 52 Week Low $6.51
  • 50 Day Moving Average 51.77
  • 200 Day Moving Average 32.49
View More

Dividends

  • Dividend Date 2018-05-14
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

OptimizeRx Corporation (OPRX) Dividend Calendar:

OPRX's last dividend payment was made to shareholders on May 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

OptimizeRx Corporation (OPRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.16$0.163.23%
2020-09-302020-11-09$N/A$0.06$0.0455.75%
2020-06-302020-08-05$N/A$0.02-$0.03166.67%
2020-03-312020-05-04$N/A-$0.06-$0.03-100%
2019-12-312020-02-27$7.38 million-$0.03$0.01-700%
2019-09-302019-11-05$5 million-$0.05$0.08-164.52%
2019-06-302019-08-07$7.01 million$0.09$0.0816.13%
2019-03-312019-05-08$5.21 million$0.06$0.02166.67%
2018-12-312019-02-26$6.58 million$0.06$0.07-18.14%
2018-09-302018-11-05$5.42 million$0.07$0.0623%
2018-06-302018-08-07$5.1 million$0.07$0.03166.8%
2018-03-312018-05-02$4.11 million$0.03-$0.03205%
2017-12-312018-02-27$4.01 million$0.02-$0.03157%
2017-09-302017-11-02$3.1 million-$0.04-$0.03-43%
2017-06-302017-08-01$2.87 million-$0.03
2017-03-312017-05-03$2.15 million-$0.09
2016-12-312017-03-08$2.29 million-$0.04
2016-09-302016-11-07$1.79 million-$0.02
2016-06-302016-08-08$1.91 million-$0.03-$0.030%
2016-03-312016-05-09$1.76 million-$0.01-$0.0366.67%
2015-12-312016-03-15$2.02 million-$0.01
2015-09-302015-11-12$2.01 million$0.01
2015-06-302015-08-11$1.71 million-$0.01
2015-03-312015-05-14$1.49 million-$0.01
2014-12-312015-03-31$1.97 million$0.00$0.01-100%
2014-09-302014-11-13$1.82 million-$0.02
2014-06-302014-08-14$1.43 million-$0.01$0.03-122.67%
2014-03-312014-05-28$1.29 million-$0.12
2013-12-312013-12-31$1.53 million-$0.01
2013-09-302013-09-30$1.37 million$0.00
2013-06-302013-06-30$1.1 million$0.03
2013-03-312013-03-31$669000-$0.02
2012-12-312012-12-31$0.07
2012-09-302012-09-30-$0.02
2012-06-302012-06-30-$0.02
2012-03-312012-03-31-$0.06
2011-12-312011-12-31-$0.11
2011-09-302011-09-30$191593-$0.21
2011-06-302011-06-30$200174-$0.09
2011-03-312011-03-31-$0.05
2010-12-312010-12-31-$0.08
2010-09-302010-09-30-$0.11
2010-06-302010-06-30-$0.20
2010-03-312010-03-31-$0.06
2009-12-312009-12-31-$0.54
2009-09-302009-09-30-$0.12
2009-06-302009-06-30-$0.08
2009-03-312009-03-31-$0.33
2008-12-312008-12-31-$0.84
2008-09-302008-09-30-$0.04
2008-06-302008-06-30-$0.14
2008-03-312008-03-31-$158.21

OptimizeRx Corporation (OPRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

OptimizeRx Corporation (OPRX) Chart:

OptimizeRx Corporation (OPRX) News:

Below you will find a list of latest news for OptimizeRx Corporation (OPRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

OptimizeRx Corporation (OPRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0575.28TRUE00
2024-05-1750CALL0 0269.59TRUE00
2024-05-177.53.4CALL0 099.9TRUE00
2024-05-17100.5CALL0 097.94FALSE00
2024-05-1712.50.15CALL0 5850FALSE00
2024-05-17150CALL0 00FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-1722.50CALL0 00FALSE00
2024-05-17250CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.50PUT0 0102.19FALSE00
2024-05-17100.8PUT0 5066.39TRUE00
2024-05-1712.50PUT0 0100.9TRUE00
2024-05-17150PUT0 0203.88TRUE00
2024-05-1717.50PUT0 0301.31TRUE00
2024-05-17200PUT0 0325.16TRUE00
2024-05-1722.50PUT0 0336.95TRUE00
2024-05-17250PUT0 0232.81TRUE00
2024-06-212.50CALL0 0334.23TRUE00
2024-06-21510CALL0 2205.31TRUE00
2024-06-217.50CALL0 074.73TRUE00
2024-06-21100.6CALL0 8467.85FALSE00
2024-06-2112.50.4CALL0 4267.03FALSE00
2024-06-21150.35CALL0 950FALSE00
2024-06-2117.50.84CALL0 120FALSE00
2024-06-21200.8CALL0 190FALSE00
2024-06-2122.50.35CALL0 10FALSE00
2024-06-21250.3CALL0 40FALSE00
2024-06-21300CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 072.65FALSE00
2024-06-21100PUT0 0101.06TRUE00
2024-06-2112.51.8PUT0 094.85TRUE00
2024-06-21153.6PUT0 25123.29TRUE00
2024-06-2117.50PUT0 0145.56TRUE00
2024-06-21200PUT0 0152.36TRUE00
2024-06-2122.50PUT0 0179.69TRUE00
2024-06-21250PUT0 0219.22TRUE00
2024-06-21300PUT0 0216.55TRUE00
2024-09-202.50CALL0 0262.06TRUE00
2024-09-2050CALL0 0124.58TRUE00
2024-09-207.50CALL0 072.59TRUE00
2024-09-20100CALL0 059.31FALSE00
2024-09-2012.50CALL0 060.65FALSE00
2024-09-20150CALL0 072.19FALSE00
2024-09-2017.50CALL0 00FALSE00
2024-09-20200CALL0 00FALSE00
2024-09-2022.50CALL0 00FALSE00
2024-09-20250CALL0 00FALSE00
2024-09-20300CALL0 00FALSE00
2024-09-202.50PUT0 00FALSE00
2024-09-2050PUT0 089.15FALSE00
2024-09-207.50.75PUT0 11168.25FALSE00
2024-09-20100PUT0 056.12TRUE00
2024-09-2012.50PUT0 058.22TRUE00
2024-09-20150PUT0 096.79TRUE00
2024-09-2017.50PUT0 0104.05TRUE00
2024-09-20200PUT0 0110.57TRUE00
2024-09-2022.50PUT0 0127.7TRUE00
2024-09-20250PUT0 0137.28TRUE00
2024-09-20300PUT0 0153.52TRUE00
2024-12-202.50CALL0 0165.58TRUE00
2024-12-2050CALL0 0108.83TRUE00
2024-12-207.50CALL0 065.59TRUE00
2024-12-20100CALL0 059.92FALSE00
2024-12-2012.50CALL0 059.37FALSE00
2024-12-20150CALL0 059.51FALSE00
2024-12-2017.50CALL0 063.64FALSE00
2024-12-20200CALL0 071.94FALSE00
2024-12-202.50PUT0 00FALSE00
2024-12-2050PUT0 075.5FALSE00
2024-12-207.50PUT0 050.84FALSE00
2024-12-20100PUT0 057.77TRUE00
2024-12-2012.50PUT0 057.72TRUE00
2024-12-20150PUT0 059.04TRUE00
2024-12-2017.50PUT0 074.05TRUE00
2024-12-20200PUT0 0106.11TRUE00
2025-01-172.50CALL0 0120.84TRUE00
2025-01-1750CALL0 089.29TRUE00
2025-01-177.52.27CALL0 359.33TRUE00
2025-01-17102.6CALL0 5058.72FALSE00
2025-01-1712.55.18CALL0 1590.88FALSE00
2025-01-17152.35CALL0 26659.22FALSE00
2025-01-1717.50CALL0 064.94FALSE00
2025-01-17201.95CALL0 776.66FALSE00
2025-01-1722.50.38CALL0 70FALSE00
2025-01-17250.25CALL0 10FALSE00
2025-01-17300.55CALL0 20FALSE00
2025-01-17350.06CALL0 220FALSE00
2025-01-172.50PUT0 00FALSE00
2025-01-1750PUT0 075.55FALSE00
2025-01-177.50PUT0 063.92FALSE00
2025-01-17101.5PUT0 1128.25TRUE00
2025-01-1712.52.25PUT0 2069.92TRUE00
2025-01-17154.2PUT0 153.95TRUE00
2025-01-1717.50PUT0 091.37TRUE00
2025-01-17200PUT0 093.51TRUE00
2025-01-1722.58.42PUT0 278.45TRUE00
2025-01-17259.23PUT0 0133.99TRUE00
2025-01-17300PUT0 0132.2TRUE00
2025-01-17350PUT0 0136.84TRUE00

Latest OPRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$25.31
Jun 13, 2022 7:59 PM EST85$25.28
Jun 13, 2022 7:59 PM EST30$25.32
Jun 13, 2022 7:59 PM EST23$25.32
Jun 13, 2022 8:45 PM EST2$25.99

OptimizeRx Corporation (OPRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-02-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1448431/000103347520000005/0001033475-20-000005-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020004998/0001213900-20-004998-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005137/0001213900-20-005137-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005258/0001213900-20-005258-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005596/0001213900-20-005596-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005688/0001213900-20-005688-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005874/0001213900-20-005874-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005969/0001213900-20-005969-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006161/0001213900-20-006161-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006356/0001213900-20-006356-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006358/0001213900-20-006358-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006360/0001213900-20-006360-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006361/0001213900-20-006361-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006460/0001213900-20-006460-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1448431/000121390020006534/0001213900-20-006534-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006751/0001213900-20-006751-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020007331/0001213900-20-007331-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/0001213900-20-007491-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008456/0001213900-20-008456-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008624/0001213900-20-008624-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008867/0001213900-20-008867-index.htm
2020-04-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008955/0001213900-20-008955-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009315/0001213900-20-009315-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009488/0001213900-20-009488-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009800/0001213900-20-009800-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020010957/0001213900-20-010957-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011117/0001213900-20-011117-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020011158/0001213900-20-011158-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011286/0001213900-20-011286-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011394/0001213900-20-011394-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012040/0001213900-20-012040-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012894/0001213900-20-012894-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020013773/0001213900-20-013773-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014568/0001213900-20-014568-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015991/0001213900-20-015991-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016166/0001213900-20-016166-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016870/0001213900-20-016870-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017235/0001213900-20-017235-index.htm
2020-07-10144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017236/0001213900-20-017236-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018238/0001213900-20-018238-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018352/0001213900-20-018352-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018775/0001213900-20-018775-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020020375/0001213900-20-020375-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020566/0001213900-20-020566-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020802/0001213900-20-020802-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021320/0001213900-20-021320-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023057/0001213900-20-023057-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023388/0001213900-20-023388-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025765/0001213900-20-025765-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020026656/0001213900-20-026656-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020027474/0001213900-20-027474-index.htm
2020-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020029583/0001213900-20-029583-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031051/0001213900-20-031051-index.htm
2020-10-16144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031790/0001213900-20-031790-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020033259/0001213900-20-033259-index.htm

OptimizeRx Corporation (OPRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OptimizeRx Corporation (OPRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1791%
Institutional Ownership: 6576%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-06DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0017.01170,100.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-13DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0018.00180,000.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-14DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07GREGORY D WASSONDirectorBuy15,000.0017.49262,350.0015,000.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-03-04WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy30,000.003.2196,300.00163,267.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-30Patrick D SpanglerDirectorBuy2,784.0017,467.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-06-30Patrick D SpanglerDirectorBuy1,937.0019,404.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-06-24WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy45,261.003.21145,287.81208,528.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-30WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy21,187.00229,719.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-03-30Ellen O'Connor VosDirectorBuy2,784.0027,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-30James Paul LangDirectorBuy2,784.0027,792.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-31Ellen O'Connor VosDirectorBuy1,000.008.758,750.0028,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-06-30James Paul LangDirectorBuy1,937.0029,729.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-06-30Ellen O'Connor VosDirectorBuy1,937.0029,959.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-03-30GUS D HALASDirectorBuy2,784.0059,960.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-06-30GUS D HALASDirectorBuy1,937.0061,897.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0020.00200,000.0080,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-07-16DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell6,667.0015.00100,005.0082,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-06-03DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy17,421.003.1554,876.1589,338.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-07-17DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy8,000.002.4619,680.0090,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.0090,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm